While both political parties have called for more goods to be “made in America,” it has been a weak request. With no real punch to this demand, the result is indifference to a critical factor in this country’s future health.
Since the novel coronavirus SARS-CoV-2, which causes the disease COVID-19, infested the United States in early March 2020, U.S. businesses have had to re-evaluate their ongoing business outlook and each company’s approach in their particular segment, whether they are large or small.
When Congress passed and President Donald Trump signed a $2 trillion aid package, historians were astounded that such an unbelievable addition to an already $20 trillion debt would be acceptable to all Americans without a murmur.
In analyzing the savage impact of COVID-19 and its disruption to America’s economy, and peoples’ lives in general, one can’t help making comparisons with previous health disasters and their unexpected shakeup on normality in the United States and abroad.
An improving image and new federal legislation could make more nuclear plants operational. Meanwhile, the growth of America’s economy continues, with only the presidential election throwing uncertainty into the mix.